Literature DB >> 15944306

Neisseria gonorrhoeae enhances infection of dendritic cells by HIV type 1.

Jizhong Zhang1, Geling Li, Andre Bafica, Milica Pantelic, Pei Zhang, Hal Broxmeyer, Ying Liu, Lee Wetzler, Johnny J He, Tie Chen.   

Abstract

Clinical studies indicate that Neisseria gonorrhoeae (gonococci (GC)) has the capacity to enhance HIV type 1 (HIV-1) infection. We studied whether GC enhances HIV infection of activated dendritic cells (DCs). The results show that GC can dramatically enhance HIV replication in human DCs during coinfection. The GC component responsible for HIV infection enhancement may be peptidoglycan, which activates TLR2. TLR2 involvement is suggested by bacterial lipoprotein, a TLR2-specific inducer, which stimulates a strong enhancement of HIV infection by human DCs. Moreover, participation of TLR2 is further implicated because GC is unable to stimulate expression of HIV in DCs of TLR2-deficient HIV-1-transgenic mice. These results provide one potential mechanism through which GC infection increases HIV replication in patients infected with both GC and HIV.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15944306     DOI: 10.4049/jimmunol.174.12.7995

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  39 in total

1.  Activation of human macrophages by bacterial components relieves the restriction on replication of an interferon-inducing parainfluenza virus 5 (PIV5) P/V mutant.

Authors:  Caitlin M Briggs; Robert C Holder; Sean D Reid; Griffith D Parks
Journal:  Microbes Infect       Date:  2010-12-24       Impact factor: 2.700

2.  RpoH mediates the expression of some, but not all, genes induced in Neisseria gonorrhoeae adherent to epithelial cells.

Authors:  Ying Du; Cindy Grove Arvidson
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

3.  Activation of NOD receptors by Neisseria gonorrhoeae modulates the innate immune response.

Authors:  Nikolaos Mavrogiorgos; Samrawit Mekasha; Yibin Yang; Michelle A Kelliher; Robin R Ingalls
Journal:  Innate Immun       Date:  2013-07-24       Impact factor: 2.680

Review 4.  Clinical parameters essential to methodology and interpretation of mucosal responses.

Authors:  Brenna L Anderson; Susan Cu-Uvin
Journal:  Am J Reprod Immunol       Date:  2011-01-12       Impact factor: 3.886

5.  Toll-Like Receptor 2 Ligation Enhances HIV-1 Replication in Activated CCR6+ CD4+ T Cells by Increasing Virus Entry and Establishing a More Permissive Environment to Infection.

Authors:  Jean-François Bolduc; Michel Ouellet; Laurent Hany; Michel J Tremblay
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

6.  TREM-2 binds to lipooligosaccharides of Neisseria gonorrhoeae and is expressed on reproductive tract epithelial cells.

Authors:  D N Quan; M D Cooper; J L Potter; M H Roberts; H Cheng; G A Jarvis
Journal:  Mucosal Immunol       Date:  2008-03-05       Impact factor: 7.313

7.  Selective Inhibition of Neisseria gonorrhoeae by a Dithiazoline in Mixed Infections with Lactobacillus gasseri.

Authors:  Jonathan D Lenz; Kristina A Shirk; Adrienne Jolicoeur; Joseph P Dillard
Journal:  Antimicrob Agents Chemother       Date:  2018-11-26       Impact factor: 5.191

8.  Human dendritic cell-specific intercellular adhesion molecule-grabbing nonintegrin (CD209) is a receptor for Yersinia pestis that promotes phagocytosis by dendritic cells.

Authors:  Pei Zhang; Mikael Skurnik; Shu-Sheng Zhang; Olivier Schwartz; Ramaswamy Kalyanasundaram; Silvia Bulgheresi; Johnny J He; John D Klena; B Joseph Hinnebusch; Tie Chen
Journal:  Infect Immun       Date:  2008-02-19       Impact factor: 3.441

9.  PPARgamma and LXR signaling inhibit dendritic cell-mediated HIV-1 capture and trans-infection.

Authors:  Timothy M Hanley; Wendy Blay Puryear; Suryaram Gummuluru; Gregory A Viglianti
Journal:  PLoS Pathog       Date:  2010-07-01       Impact factor: 6.823

10.  The synthetic bacterial lipopeptide Pam3CSK4 modulates respiratory syncytial virus infection independent of TLR activation.

Authors:  D Tien Nguyen; Lot de Witte; Martin Ludlow; Selma Yüksel; Karl-Heinz Wiesmüller; Teunis B H Geijtenbeek; Albert D M E Osterhaus; Rik L de Swart
Journal:  PLoS Pathog       Date:  2010-08-19       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.